Systemic inflammatory cells fight off neurodegenerative disease (Q37763505)

22 August 2017

1 reference

title

Systemic inflammatory cells fight off neurodegenerative disease (English)

1 reference

22 August 2017

0 references

1 reference

1

Michal Schwartz

1 reference

22 August 2017

2

Ravid Shechter

1 reference

PubMed ID

20531383

22 August 2017

language of work or name

English

0 references

publication date

8 June 2010

1 reference

22 August 2017

Nature Reviews Neurology

1 reference

22 August 2017

6

1 reference

22 August 2017

7

1 reference

22 August 2017

405-410

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2010.71

22 August 2017

0 references

cites work

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Molecular biology of amyotrophic lateral sclerosis: insights from genetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Anti-inflammatory drugs and Alzheimer disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Polymorphisms in inflammatory genes and the risk of Alzheimer disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Trial of celecoxib in amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Can the immune system be harnessed to repair the CNS?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Microglial NO induces delayed neuronal death following acute injury in the striatum.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

From bone marrow to microglia: barriers and avenues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Immune activation in brain aging and neurodegeneration: too much or too little?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Taking advantage of the systemic immune system to cure brain diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Inflammation in neurodegenerative disease--a double-edged sword

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Protective autoimmunity against the enemy within: fighting glutamate toxicity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Immunity and cognition: what do age-related dementia, HIV-dementia and 'chemo-brain' have in common?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Vaccination as a novel approach for treating depressive behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Immune senescence and brain aging: can rejuvenation of immunity reverse memory loss?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Altered lymphocyte distribution in Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Biomarkers of Alzheimer disease in plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Three or more routes for leukocyte migration into the central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Protective autoimmunity functions by intracranial immunosurveillance to support the mind: The missing link between health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.71

Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20531383

12 December 2020

inferred from PubMed ID database lookup

Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20531383

12 December 2020

inferred from PubMed ID database lookup

Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20531383

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/NRNEUROL.2010.71

1 reference

release_fof3hx6e5zetdmxqbxdfg7rwle

22 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fof3hx6e5zetdmxqbxdfg7rwle

24 November 2022

mapped directly with Wikidata item

PubMed ID

20531383

1 reference

PubMed ID

20531383